Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Zynerba Pharma CS (ZYNE)

Zynerba Pharma CS (ZYNE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Zynerba Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Zynerba Pharmaceuticals, Inc. To Contact The Firm

New York, New York--(Newsfile Corp. - November 19, 2019) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) ("Zynerba" or...

ZYNE : 6.38 (+3.40%)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zynerba Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline- ZYNE

Pomerantz LLP announces that a class action lawsuit has been filed against Zynerba Pharmaceuticals, Inc. ("Zynerba" or the "Company") (NASDAQ: ZYNE) and certain of its officers. The class action, filed...

ZYNE : 6.38 (+3.40%)
Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against iRobot Corporation (IRBT), Zendesk, Inc. (ZEN) & Zynerba Pharmaceuticals, Inc. (ZYNE)

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints...

IRBT : 46.41 (-0.58%)
ZEN : 77.47 (+0.34%)
ZYNE : 6.38 (+3.40%)
Zynerba Pharmaceuticals Enters Oversold Territory

Zynerba Pharmaceuticals has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.

ZYNE : 6.38 (+3.40%)
Zynerba Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Zynerba Pharmaceuticals, Inc. To Contact The Firm

New York, New York--(Newsfile Corp. - November 15, 2019) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) ("Zynerba" or...

ZYNE : 6.38 (+3.40%)
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Zynerba, iRobot, Zendesk, and PG&E Corporation and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, reminds investors that class action lawsuits have been commenced on behalf of stockholders of Zynerba Pharmaceuticals, Inc. (NASDAQ:...

ZYNE : 6.38 (+3.40%)
IRBT : 46.41 (-0.58%)
ZEN : 77.47 (+0.34%)
PCG : 6.84 (-3.53%)
Zynerba Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Zynerba Pharmaceuticals, Inc. To Contact The Firm

New York, New York--(Newsfile Corp. - November 13, 2019) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) ("Zynerba" or...

ZYNE : 6.38 (+3.40%)
SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Zynerba Pharmaceuticals, Inc.- ZYNE

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) from March 11, 2019 through September...

ZYNE : 6.38 (+3.40%)
Zynerba Pharmaceuticals Receives New U.S. Patent for Treatment of Fragile X Syndrome with Transdermal Cannabidiol

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced that...

ZYNE : 6.38 (+3.40%)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zynerba Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline- ZYNE

Pomerantz LLP announces that a class action lawsuit has been filed against Zynerba Pharmaceuticals, Inc. ("Zynerba" or the "Company") (NASDAQ: ZYNE) and certain of its officers. The class action, filed...

ZYNE : 6.38 (+3.40%)
SHAREHOLDER ALERT - Zynerba Pharmaceuticals, Inc. (ZYNE) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: December 23, 2019

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Zynerba Pharmaceuticals, Inc. ("Zynerba" or the "Company") (ZYNE) and certain...

ZYNE : 6.38 (+3.40%)
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Zynerba, iRobot, Zendesk, and Abeona and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, reminds investors that class action lawsuits have been commenced on behalf of stockholders of Zynerba Pharmaceuticals, Inc. (NASDAQ:...

ZYNE : 6.38 (+3.40%)
IRBT : 46.41 (-0.58%)
ZEN : 77.47 (+0.34%)
ABEO : 2.33 (+4.26%)
Zynerba: 3Q Earnings Snapshot

DEVON, Pa. (AP) _ Zynerba Pharmaceuticals Inc. (ZYNE) on Wednesday reported a loss of $1.9 million in its third quarter.

ZYNE : 6.38 (+3.40%)
Zynerba Pharmaceuticals Reports Third Quarter 2019 Financial Results and Operational Highlights

- Positive Topline Results from BELIEVE 1 Phase 2 Trial of Zygel(TM) in Children and Adolescents with Developmental and Epileptic Encephalopathies Suggest Compelling Seizure Reductions and Excellent Tolerability...

ZYNE : 6.38 (+3.40%)
Zynerba Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Zynerba Pharmaceuticals, Inc. To Contact The Firm

New York, New York--(Newsfile Corp. - November 5, 2019) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) ("Zynerba" or...

ZYNE : 6.38 (+3.40%)
Zynerba Pharmaceuticals (ZYNE) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Zynerba Pharmaceuticals (ZYNE) closed at $7.44, marking a -0.53% move from the previous day.

ZYNE : 6.38 (+3.40%)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zynerba Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - ZYNE

Pomerantz LLP announces that a class action lawsuit has been filed against Zynerba Pharmaceuticals, Inc. ("Zynerba" or the "Company") (NASDAQ: ZYNE) and certain of its officers. The class action, filed...

ZYNE : 6.38 (+3.40%)
What's in the Cards for Zynerba (ZYNE) This Earnings Season?

Zynerba Pharmaceuticals' (ZYNE) operating expenses are expected to have increased in the third quarter driven by clinical studies on its lead pipeline candidate, Zygel.

AMRN : 22.73 (+0.58%)
FOLD : 9.76 (+1.88%)
ZYNE : 6.38 (+3.40%)
EYEN : 3.00 (+9.09%)
INVESTOR ALERT - Zynerba Pharmaceuticals, Inc. (ZYNE) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: December 23, 2019

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Zynerba Pharmaceuticals, Inc. ("Zynerba" or the "Company") (ZYNE) and certain...

ZYNE : 6.38 (+3.40%)
INVESTOR CLASS ACTION DEADLINES: Bernstein Liebhard LLP Reminds Investors in TEUM, INFY, and ZYNE of Filing Deadlines

Bernstein Liebhard LLP announces that class action complaints have been filed on behalf of shareholders of TEUM, INFY, and ZYNE. If you wish to serve as lead plaintiff, you must move the court by the lead...

TEUM : 0.37 (unch)
INFY : 9.83 (-0.30%)
ZYNE : 6.38 (+3.40%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI -1.62 , AIZ -0.39 , SBAC +3.83 , SO -0.27 , WELL +0.28
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar